Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editors-in-Chief, Associate Editors and Section Editors for this issue.
Linda S. Sher
Dr Sher is Professor of Clinical Surgery and Director of Clinical Research in the Division of Hepatobiliary Surgery and Abdominal Organ Transplantation at Keck School of Medicine, University of Southern California (USC), USA. After completing her medical school education and surgical residency at Mount Sinai School of Medicine in New York, USA, Dr Sher undertook her fellowship training in Liver and Kidney Transplantation at the University of Pittsburgh, USA. After completing her fellowship in 1988, Dr Sher was involved in the establishment of two liver transplant programs in Los Angeles prior to joining the USC program in 2001. Dr Sher has participated in and overseen over 50 research projects and is currently very active in the development of the clinical and basic science research components of the USC Abdominal Organ Transplantation Program. She has numerous publications on immunosuppression, chronic rejection, disease recurrence, infection, and hepatobiliary surgery.
Dr Sher is one of the original editors of Current Opinion in Organ Transplantation and has endeavored over the years to provide the reader with an up to date overview of the entire field of organ transplantation.
Josep M. Grinyó
Josep Grinyó, MD, PhD, is the Chief of Nephrology at the University Hospital of Bellvitge, Spain, and Full Professor of Medicine at the University of Barcelona, Department of Medicine, Spain. Dr Grinyó's research work on renal transplantation has been focused on immunosuppression, ischemia-reperfusion injury and chronic allograft damage in the clinical setting and in experimental animal models.
Josep Grinyó is Associate Editor of the Current Opinion in Transplantation, Transplant International, Consulting Editor of the American Journal of Transplantation and member of the editorial boards of Transplantation and Kidney International
Josep Grinyó has authored or co-authored over 300 articles and given more than 200 invited lectures.
Jerzy W. Kupiec-Weglinski
Dr Kupiec-Weglinski is the Director of Dumont-University of California, Los Angeles (UCLA) Transplant Research Laboratories in Los Angeles, USA. He is Professor of Surgery and Pathology, and Vice-Chairman, Department of Surgery (Research), at the David Geffen School of Medicine at UCLA. He holds the Joan S. and Ralph N. Goldwyn Endowed Chair in Transplantation Research. Dr Kupiec-Weglinski's interests focus on the immunobiology of organ ischemia and reperfusion injury, host sensitization, and tolerance induction in transplant recipients. He has authored over 400 papers. His research for the last 28 years has been funded by National Institute of Health (NIH). He served as standing member of the Transplantation, Tolerance and Tumor Immunology (TTT) NIH Study Section, as member of the board of directors of American Society of Transplantation, and recipient of the AST/Astellas Established Investigator Award in Basic Transplant Research. He holds the Honorary Doctorate (“Honoris Causa”) from Medical Academy in Warsaw, and is the Foreign Member of Polish Academy of Sciences.
Dr Paolo Cravedi, MD, PhD is an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai, New York. He received his MD summa cum laude from the University of Milan, Italy and then he specialized in internal medicine and nephrology at the University of Parma (both in Italy). He obtained his PhD in Immunology from the Open University of London, England.
His lab is mainly interested in T cell exhaustion, in the immune modulating effects of erythropoietin, and in the identification of biomarkers in organ transplantation.
Paolo Cravedi is an Associate Editor of the Journal of Nephrology and Plos One. He has authored or co-authored over 100 articles and given more than 50 invited talks.
Dr Ryutaro Hirose, MD is an abdominal transplant surgeon and Professor in Surgery at the University of California, San Francisco, USA where he performs liver, pancreas and kidney transplant surgery. He graduated from Columbia College of Physicians and Surgeons, and completed his surgical residency and transplant surgery fellowship at UCSF. His areas of interest and expertise include surgical education, quality improvement and patient safety as well as transplantation outcomes, ischemia-reperfusion injury, management of hepatocellular carcinoma and organ allocation policy.
Yasir A. Qazi
Dr Yasir A. Qazi is an Associate Professor of Medicine and the Medical Director of the Kidney and Pancreas transplant program at the University of Southern California, Keck School of Medicine in Los Angeles, California, USA. Dr Qazi received his medical degree from the Kashmir University in Srinagar, Kashmir, India. He completed his internal medicine residency and a fellowship in Nephrology at the State University of New York in Buffalo, NY, USA. He also completed an American Society of Transplant Certified Transplant Nephrology fellowship at State University of New York, Downstate Medical Center in Brooklyn, New York, USA. Prior to being the Medical Director at Keck Medical Center, he started and was the Medical Director of the Pancreas transplant program at Erie county Medical Center, Buffalo, NY. He has been a lead Principal Investigator on several clinical trials involving organ transplantation. Dr Qazi's research interests include increasing utilization of marginal kidneys especially kidneys from donors with acute kidney injury. His other interests include BK nephropathy, disparities in transplant referral of patients, simultaneous kidney and pancreas transplant in type 2 diabetics and antibodies in kidney transplantation.